These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 18452548

  • 1. Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia.
    Simanovsky M, Berlinsky S, Sinai P, Leiba M, Nagler A, Galski H.
    Differentiation; 2008 Oct; 76(8):908-22. PubMed ID: 18452548
    [Abstract] [Full Text] [Related]

  • 2. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 Oct; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 3. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A, Pattacini L, Goldman JM, Melo JV.
    Cancer Res; 2005 Oct 01; 65(19):8912-9. PubMed ID: 16204063
    [Abstract] [Full Text] [Related]

  • 4. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B, Pasternak G, Hehlmann R.
    Folia Biol (Praha); 2000 Oct 01; 46(6):256-63. PubMed ID: 11140859
    [Abstract] [Full Text] [Related]

  • 5. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
    Deininger MW, Vieira S, Mendiola R, Schultheis B, Goldman JM, Melo JV.
    Cancer Res; 2000 Apr 01; 60(7):2049-55. PubMed ID: 10766197
    [Abstract] [Full Text] [Related]

  • 6. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 7. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S, Cruz M, Rabelo L, Godínez R, Reyes-Maldonado E, Riebeling-Navarro C.
    Eur J Haematol; 2004 Apr 15; 72(4):231-8. PubMed ID: 15089759
    [Abstract] [Full Text] [Related]

  • 8. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar 15; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 9. Chronic myelogenous leukemia molecular signature.
    Nowicki MO, Pawlowski P, Fischer T, Hess G, Pawlowski T, Skorski T.
    Oncogene; 2003 Jun 19; 22(25):3952-63. PubMed ID: 12813469
    [Abstract] [Full Text] [Related]

  • 10. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M, Maeda H, Hara H, Yamamoto Y, Furuyama J.
    Stem Cells; 1993 Nov 19; 11(6):536-42. PubMed ID: 7509222
    [Abstract] [Full Text] [Related]

  • 11. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M, Piazza RG, Pirola A, Redaelli S, Mogavero A, Iacobucci I, Meneghetti I, Parma M, Pogliani EM, Gambacorti-Passerini C.
    Leukemia; 2010 Aug 19; 24(8):1445-9. PubMed ID: 20520635
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
    Nimmanapalli R, Fuino L, Bali P, Gasparetto M, Glozak M, Tao J, Moscinski L, Smith C, Wu J, Jove R, Atadja P, Bhalla K.
    Cancer Res; 2003 Aug 15; 63(16):5126-35. PubMed ID: 12941844
    [Abstract] [Full Text] [Related]

  • 13. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG, Tarpey PS, Nacheva EP.
    Genes Chromosomes Cancer; 2003 Jul 15; 37(3):282-90. PubMed ID: 12759926
    [Abstract] [Full Text] [Related]

  • 14. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):60-4. PubMed ID: 18068536
    [Abstract] [Full Text] [Related]

  • 15. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
    Lindner I, Kharfan-Dabaja MA, Ayala E, Kolonias D, Carlson LM, Beazer-Barclay Y, Scherf U, Hnatyszyn JH, Lee KP.
    J Immunol; 2003 Aug 15; 171(4):1780-91. PubMed ID: 12902478
    [Abstract] [Full Text] [Related]

  • 16. Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.
    Pullarkat ST, Vardiman JW, Slovak ML, Rao DS, Rao NP, Bedell V, Said JW.
    Leuk Res; 2008 Nov 15; 32(11):1770-5. PubMed ID: 18417213
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma.
    Leone G, La Rocca LM, Teofili L, De Candia E, Landolfi R, Sica S, Zini G, Zollino M, Tabilio A.
    Haematologica; 1992 Nov 15; 77(4):311-4. PubMed ID: 1427440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.